These findings indicate that MYC might positively regulate CXCR4 transcript levels in B-cell lymphoma, which could dampen the additional effect of CXCR4 hyperactivation by CXCR4C1013G. Here, CXCR4 is linked to B-cell non-Hodgkin lymphoma.